Recent News

Second US rejection for AZ’ potassium binder

AstraZeneca’s hyperkalaemia treatment ZS-9 has suffered another setback on the path to US approval having been rejected by regulators for the second time. The drug giant also unveiled a US-based partnership with Circassia for development and commercialisation of COPD drugs Turdoza and Duaklir.


Original Link...

Tags: medical, MEDICINE, pharmaceuticals
0 Volde

Read On: